Health care utilization and costs for children and adults with duchenne muscular dystrophy

Lucinda J Teoh1, Elizabeth A Geelhoed2, Klair Bayley2

  • 1School of Population Health, The University of Western Australia, Crawley, Western Australia, Australia.

Muscle & Nerve
|November 13, 2015
PubMed

Insights

The economic burden of Duchenne muscular dystrophy (DMD) in Australia is substantial, with annual costs averaging $46,700 per individual. Healthcare expenses represent a significant portion, highlighting the socioeconomic impact of this childhood neuromuscular disorder.

Area of Science:

  • Medical Economics
  • Neuromuscular Disorders
  • Public Health

Background:

  • Duchenne muscular dystrophy (DMD) is a severe childhood neuromuscular disorder with significant, yet unquantified, economic implications in Australia.
  • Existing healthcare, caregiving, and resource needs suggest a substantial economic burden for families affected by DMD.

Purpose of the Study:

  • To assess the specific economic burden of Duchenne muscular dystrophy within Australian households.
  • To quantify annual resource utilization and associated costs for individuals with DMD in Australia.

Main Methods:

  • A cross-sectional survey was administered to Australian households with a child diagnosed with DMD.
  • Data collected included annual resource utilization for healthcare services, equipment, home modifications, informal care, and lost workdays.

Main Results:

  • Mean annual healthcare costs reached $10,046 per individual with DMD, exceeding average Australian health expenditures across all age groups.
  • The overall mean total economic cost was $46,700 (median $32,300), with healthcare costs comprising 22% of the total burden.

Conclusions:

  • Duchenne muscular dystrophy imposes a high annual economic cost, signifying a considerable socioeconomic burden in Australia.
  • The economic and caregiving burden is particularly pronounced for males with DMD as they approach adulthood.
Abstract

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
744
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
751